"geriatric syndrom; hypoglycemia; diabetes mellitus; older patients"@en . "RIV/00216208:11150/14:10290765!RIV15-MSM-11150___" . . "Diabetes mellitus 2. typu ve st\u00E1\u0159\u00ED" . . "1"^^ . "L\u00E1\u0161ticov\u00E1, Martina" . "3" . "Diabetes mellitus"@en . "[CAD1437053D7]" . "1805-4684" . "Diabetes mellitus 2. typu ve st\u00E1\u0159\u00ED"@cs . "1"^^ . . "CZ - \u010Cesk\u00E1 republika" . "Diabetes mellitus"@en . . "Star\u0161\u00ED pacienti s diabetem maj\u00ED vy\u0161\u0161\u00ED morbiditu a mortalitu oproti nediabetick\u00FDm pacient\u016Fm. K \u010Dast\u00FDm probl\u00E9m\u016Fm t\u011Bchto pacient\u016F pat\u0159\u00ED polypragmazie, funk\u010Dn\u00ED dis-abilita a geriatrick\u00E9 syndromy - kognitivn\u00ED poruchy, deprese, mo\u010Dov\u00E1 inkontinence a p\u00E1dy. P\u0159i rozhodov\u00E1n\u00ED o zp\u016Fsobu l\u00E9\u010Dby a stanovov\u00E1n\u00ED c\u00EDl\u016F l\u00E9\u010Dby je nutn\u00E9 zv\u00E1\u017Eit samostatnost, pohybov\u00E9 a ment\u00E1ln\u00ED schopnosti pacienta. D\u016Fle\u017Eit\u00FDm faktorem p\u0159i v\u00FDb\u011Bru antidiabetick\u00E9 medikace je riziko hypoglykemie, kter\u00E9 je v t\u00E9to skupin\u011B pacient\u016F zv\u00FD\u0161en\u00E9 a m\u016F\u017Ee v\u00E9st ke zhor\u0161ov\u00E1n\u00ED kognitivn\u00EDch funkc\u00ED a funk\u010Dn\u00ED disabilit\u011B." . "4"^^ . "11150" . "Diabetes mellitus 2. typu ve st\u00E1\u0159\u00ED" . "2" . . "RIV/00216208:11150/14:10290765" . . "Star\u0161\u00ED pacienti s diabetem maj\u00ED vy\u0161\u0161\u00ED morbiditu a mortalitu oproti nediabetick\u00FDm pacient\u016Fm. K \u010Dast\u00FDm probl\u00E9m\u016Fm t\u011Bchto pacient\u016F pat\u0159\u00ED polypragmazie, funk\u010Dn\u00ED dis-abilita a geriatrick\u00E9 syndromy - kognitivn\u00ED poruchy, deprese, mo\u010Dov\u00E1 inkontinence a p\u00E1dy. P\u0159i rozhodov\u00E1n\u00ED o zp\u016Fsobu l\u00E9\u010Dby a stanovov\u00E1n\u00ED c\u00EDl\u016F l\u00E9\u010Dby je nutn\u00E9 zv\u00E1\u017Eit samostatnost, pohybov\u00E9 a ment\u00E1ln\u00ED schopnosti pacienta. D\u016Fle\u017Eit\u00FDm faktorem p\u0159i v\u00FDb\u011Bru antidiabetick\u00E9 medikace je riziko hypoglykemie, kter\u00E9 je v t\u00E9to skupin\u011B pacient\u016F zv\u00FD\u0161en\u00E9 a m\u016F\u017Ee v\u00E9st ke zhor\u0161ov\u00E1n\u00ED kognitivn\u00EDch funkc\u00ED a funk\u010Dn\u00ED disabilit\u011B."@cs . . . "Older patients with diabetes have higher morbidity and mortality compared to non-diabetic patients. Common problems of these patients are polypharmacy, functional dysability and geriatric syndroms-cognitive dysfunction, depression, urinary continence and falls. Decision about treatment and goals of treatment should be guided by dependency, mobility and mental condition of the patients. When deciding for a antidiabetic medication, its important to consider a risk of hypoglycemia, which is increased in this group of patients, and can be a cause of cognitive deterioration and functional dysability."@en . "Diabetes mellitus 2. typu ve st\u00E1\u0159\u00ED"@cs . . . . . "11127" . "I" . . "Geriatrie a gerontologie" . . .